Keyphrases
Adoptive Cell Therapy
40%
Antigen-specific
10%
Array Size
20%
Biotechnology Firms
10%
CD8+ Cytotoxic T Lymphocytes
20%
CD8+ T Lymphocytes
100%
Cell Array
20%
Cell Identification
20%
Cell Isolation
80%
Cell-based
50%
Chapel Hill
10%
Clinical Tool
20%
Commercially Available
10%
Cytotoxic T Cells
100%
Cytotoxicity Assay
40%
Epitope
10%
Ex Vivo Expansion
10%
Expressed Protein
20%
Feasibility Trial
20%
Fluorescence Characteristics
20%
Fluorescence Signatures
20%
Grant Applications
10%
High Efficiency
20%
High-throughput Image
20%
High-throughput Technologies
20%
Highly Active
10%
Highly Effective
50%
Image Cytometry
20%
Isolation Method
40%
Killer T Cells
20%
Killing Efficiency
20%
Leukemia
10%
Lymphocytes
10%
Market Application
20%
Microarray
10%
Microsystems
10%
Molecular Characteristics
20%
Molecular Characterization
10%
Natural Killer Cells
10%
Non-adherent
40%
Release Devices
20%
Selection Criteria
20%
Solid Tumors
10%
T Cell Receptor
10%
Time-resolved
20%
Tumor
20%
Tumor Antigen
10%
Tumor Cells
10%
University of North Carolina
10%
Viable Cells
20%
Medicine and Dentistry
Antigen Specificity
16%
CD8+ T Lymphocyte
100%
Cell Therapy
41%
Cells of the Immune System
16%
Cytotoxic T-Cell
100%
Cytotoxicity Assay
33%
Epitope
8%
Ex Vivo
8%
Health Care Cost
8%
Image Cytometry
16%
Immunotherapy
8%
Killer Cell
16%
Leukemia
8%
Lymphocyte
8%
Morphology
8%
Neoplasm
16%
Solid Malignant Neoplasm
8%
T Cell
8%
T Lymphocyte Receptor
16%
Tumor Antigen
8%
Tumor Cell
8%
Immunology and Microbiology
Antigen Specificity
8%
CD8+ T Lymphocyte
100%
Cell Isolation
50%
Cells of the Immune System
16%
Cytotoxic T Cell
100%
Cytotoxicity
16%
Epitope
8%
Immunotherapy
8%
Isolation Procedure
33%
Killer Cell
16%
Lymphocyte
8%
Morphology
16%
Scale up
8%
Surface Property
8%
T Cell
8%
T Cell Receptor
8%
Tumor Antigen
8%
Tumor Cell
8%